Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
100.21 USD | +0.12% | +1.07% | +0.84% |
Jan. 13 | Merck & Co., Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 04:30 PM | |
Jan. 13 | GSK Acquiring US-Based IDRx for up to $1.15 Billion | MT |
Chart calendar Merck & Co., Inc.
Upcoming events on Merck & Co., Inc.
Past events on Merck & Co., Inc.
2025-01-13 07:30 pm | JP Morgan Healthcare Conference |
2024-12-15 | Détachement de |
2024-12-05 08:00 am | Citi Global Healthcare Conference |
2024-12-03 01:20 pm | Evercore ISI HealthCONx Conference |
2024-11-21 06:30 am | Jefferies London Healthcare Conference |
2024-11-13 12:30 pm | UBS Global Healthcare Conference |
2024-11-11 | International Papillomavirus Conference - ID #2172 |
2024-11-11 | International Papillomavirus Conference - Poster #230 |
2024-11-11 | International Papillomavirus Conference - Poster #209 |
2024-11-11 | International Papillomavirus Conference - Poster #219 |
2024-11-11 | International Papillomavirus Conference - Poster #229 |
2024-11-11 | International Papillomavirus Conference - ID#1292 |
2024-11-11 | International Papillomavirus Conference - ID#2397 |
2024-11-11 | International Papillomavirus Conference - Poster #228 |
2024-10-31 09:00 am | Q3 2024 Earnings Call |
2024-10-31 06:30 am | Q3 2024 Earnings Release |
2024-10-15 | IDWeek Conference - Abstract No - #1113 |
2024-10-15 | IDWeek Conference - Abstract No - #1076 |
2024-10-15 | IDWeek Conference - Abstract No - #1074 |
2024-10-15 | IDWeek Conference - Abstract No - #58 |
Past dividends on Merck & Co., Inc.
2024-12-15 | Quarterly 0.81 USD |
2024-09-15 | Quarterly 0.77 USD |
2024-06-16 | Quarterly 0.77 USD |
2024-03-13 | Quarterly 0.77 USD |
2023-12-13 | Quarterly 0.77 USD |
2023-09-13 | Quarterly 0.73 USD |
2023-06-13 | Quarterly 0.73 USD |
2023-03-13 | Quarterly 0.73 USD |
2022-12-13 | Quarterly 0.73 USD |
2022-09-13 | Quarterly 0.69 USD |
2022-06-13 | Quarterly 0.69 USD |
2022-03-13 | Quarterly 0.69 USD |
2021-12-13 | Quarterly 0.69 USD |
2021-09-13 | Quarterly 0.65 USD |
2021-06-13 | Quarterly 0.65 USD |
2021-03-11 | Quarterly 0.65 USD |
2020-12-13 | Quarterly 0.65 USD |
2020-09-13 | Quarterly 0.61 USD |
2020-06-11 | Quarterly 0.61 USD |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 48 704 48 367 0.7% | 59 283 59 144 0.24% | 60 115 59 938 0.3% | 64 006 | 67 497 | 71 414 |
EBITDA Million USD | Released Forecast Spread | 20 910 19 760 5.82% | 26 431 24 588 7.5% | 10 083 9 362 7.71% | 26 832 | 31 499 | 33 863 |
EBIT Million USD | Released Forecast Spread | 17 696 17 554 0.81% | 22 522 22 363 0.71% | 6 211 6 066 2.4% | 23 574 | 28 070 | 30 677 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 13 879 12 048 15.2% | 16 444 17 389 -5.44% | 1 889 2 857 -33.89% | 21 480 | 25 428 | 28 621 |
Net income Million USD | Released Forecast Spread | 13 049 11 797 10.61% | 14 519 14 827 -2.07% | 365 1 682 -78.3% | 17 612 | 21 954 | 24 447 |
EPS USD | Released Forecast Spread | 5,14 4,70 9.39% | 5,71 5,87 -2.73% | 0,14 0,56 -75.16% | 7,05 | 8,79 | 9,65 |
Announcement Date | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 14 487 13 799 4.98% | 15 035 14 444 4.09% | 15 962 15 273 4.51% | 14 630 14 480 1.03% | 15 775 15 204 3.75% | 16 112 15 844 1.69% | 16 657 16 514 0.87% | 15 553 | 16 406 | 16 834 | 17 462 | 16 776 | 17 331 | 17 447 | 18 348 |
EBITDA Million USD | Released Forecast Spread | 5 402 5 058 6.8% | -3 485 -3 901 10.67% | 7 538 6 724 12.1% | 665 1 985 -66.49% | 7 367 6 562 12.27% | 7 177 7 367 -2.57% | 5 466 5 999 -8.89% | 9 073 | |||||||
EBIT Million USD | Released Forecast Spread | 4 411 4 088 7.89% | -4 388 -4 683 6.29% | 6 524 5 967 9.33% | -299 -476 37.23% | 6 383 5 808 9.91% | 6 659 6 519 2.14% | 4 913 5 046 -2.63% | 5 578 | 7 044 | 7 177 | 7 335 | 6 273 | 7 612 | 7 477 | 7 823 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 650 4 190 -12.89% | -5 335 -4 682 -13.95% | 5 620 5 023 11.89% | -2 046 -1 249 -63.78% | 5 670 5 267 7.66% | 6 006 6 023 -0.29% | 4 090 4 535 -9.82% | 4 988 | |||||||
Net income Million USD | Released Forecast Spread | 2 821 3 133 -9.97% | -5 975 -6 154 2.9% | 4 745 4 224 12.34% | -1 226 -919 -33.43% | 4 762 4 414 7.88% | 5 455 4 942 10.38% | 3 157 3 419 -7.66% | 4 027 | 5 323 | 5 356 | 5 551 | 4 663 | 5 780 | 5 681 | 5 968 |
EPS USD | Released Forecast Spread | 1,11 1,21 -8.14% | -2,35 -2,44 3.61% | 1,86 1,65 12.59% | -0,48 -0,35 -37.91% | 1,87 1,79 4.45% | 2,14 1,93 10.86% | 1,24 1,43 -13.39% | 1,64 | 2,10 | 2,12 | 2,21 | 1,86 | 2,31 | 2,28 | 2,40 |
Announcement Date | 27/04/23 | 01/08/23 | 26/10/23 | 01/02/24 | 25/04/24 | 30/07/24 | 31/10/24 | - | - | - | - | - | - | - | - |
Past sector events for Merck & Co., Inc.
2025-01-10 07:00 am | TILRAY BRANDS, INC.: Q2 2025 Earnings Release |
2025-01-10 04:09 am | LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-09 06:50 pm | BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-09 05:25 am | SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release |
2025-01-08 | HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release |
2025-01-08 03:17 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
2024-12-10 11:45 am | MEDINCELL S.A.: Q2 2025 Earnings Release |
2024-12-10 04:02 am | LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release |
2024-12-10 01:29 am | CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release |
2024-12-09 04:04 am | SCINOPHARM TAIWAN, LTD.: November 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Calendar Merck & Co., Inc.